Shoulder RA Survey Study

NCT07641842 | Not Yet Recruiting

• 2 other identifiers: 25-6110CTO Project ID# 5621
• Study Type: observational
• Target: 140
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study, called a cross-sectional survey, is to interview patients on their experiences of pain and recovery following keyhole shoulder surgery, after receiving a single shot nerve block in addition to a general anesthetic. The researchers would like to explore patients' experiences to see if there are groups of patients who may benefit from insertion of a nerve catheter as compared to a single shot nerve block injection for keyhole shoulder surgery.

Conditions

Nerve Block

Keywords

Nerve block; Nerve catheter block; Shoulder Arthroscopic Surgery; Survey; Continuous nerve block catheter infusion

Outcome Measures

Primary Outcomes (1)

• To determine the proportion of patients who have a preference for nerve block with a continuous infusion versus a single injection of local anesthetic

  To determine the proportion of patients undergoing outpatient arthroscopic shoulder surgery who have a preference for prolongation of their peripheral nerve block with a continuous infusion versus a single injection of local anesthetic

  Through study completion, an average of 1 year

Secondary Outcomes (6)

• To determine predictive factors for catheter preference based on demographic characteristics

  Through study completion, an average of 1 year

• To determine predictive factors for catheter preference based on type and duration of shoulder surgery

  Through study completion, an average of 1 year

• To determine predictive factors for catheter preference based on pre-operative anxiety defined by the PROMIS Anxiety Scale short form 8a

  Through study completion, an average of 1 year

• To determine predictive factors for catheter preference based on pre-operative frailty

  Through study completion, an average of 1 year

• To identify the incidence of rebound pain following single-injection PNB (Peripheral Nerve Block)

  Through study completion, an average of 1 year

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients scheduled for for an arthroscopic shoulder surgery at Toronto Western Hospital and Women's College Hospital, Toronto.

You may qualify if:

• Patients receiving a single-injection PNB for outpatient arthroscopic shoulder surgery at TWH and WCH
• Age ≥18 years
• Able to communicate in English

You may not qualify if:

• Cognitive impairment (inability to consent to participate in study)
• Refusal to participate in study
• Patients with primary block failure defined as those without a detectable sensory or motor block (determined by inability to abduct the arm and numbness or loss of sensation to pinprick over lateral shoulder/deltoid muscle, C5 dermatome)

Sponsors & Collaborators

• University Health Network, Toronto: lead

Study Sites (1)

Toronto Western Hospital, University Health Network

Toronto, Ontario, M5T 2S8, Canada

Location

Study Officials

• Ki Jinn Chin, MBBS MD FRCPC

  University Health Network, Toronto

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Jayanta Chowdhury

CONTACT

4166035800; jayanta.chowdhury@uhn.ca

Ki Jinn Chin, MBBS MD FRCPC

CONTACT

KiJinn.Chin@uhn.ca

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 7, 2026
• First Posted: June 11, 2026
• Study Start: May 15, 2026
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2026
• Last Updated: June 11, 2026

Record last verified: 2026-04

Locations

CA (1)